Mild Disease Course of Experimental Autoimmune Encephalomyelitis without Pertussis Toxin: Brain Transcriptome Analysis Reveals Similar Signaling to Active Lesions in Multiple Sclerosis
Open Access
- 30 May 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (6) , 1215
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a powerful model to study multiple sclerosis (MS). One of the approaches for EAE is to actively immunize with myelin-derived peptides with immune adjuvants. One of the commonly used immune adjuvants is pertussis toxin (PTx), without which EAE disease is mild with relatively longer onset. However, pertussis toxin can also inhibit G protein-coupled receptor (GPCR) signaling so it can confound investigations into the role of GPCRs in EAE or therapies designed to target GPCRs. Since EAE via active immunization without PTx results in a relatively mild disease state, we wanted to confirm that appropriate signaling molecules for the disease were being induced in one target tissue (i.e., brain). RNA-Seq analysis of whole brain tissue demonstrated that the MS signaling pathway was strongly activated in symptomatic mice. In addition, there was activation of Th1 (IFN signaling), Th2 (IL-4 signaling), and Th17 (IL-17 signaling). In comparing canonical pathways from our mouse mild EAE brains with a human MS atlas, EAE shared the most pathways with active and inactive lesions. An advantage of this approach is that disease induction is slower to develop and results in modest clinical signs, which likely more closely mimic human disease onset.Keywords
Funding Information
- NIH (P20GM103646)
- Mississippi State University College of Veterinary Medicine (P20GM103646)
This publication has 45 references indexed in Scilit:
- Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune EncephalomyelitisJournal of Neuroimmune Pharmacology, 2021
- Diversity of molecular targets and signaling pathways for CBDPharmacology Research & Perspectives, 2020
- CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of NeuroinflammationJournal of Neuroimmune Pharmacology, 2020
- Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter studyNeurological Sciences, 2020
- Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitisJournal of Neuroscience Research, 2018
- Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitisExperimental Neurology, 2017
- IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathwayBrain, Behavior, and Immunity, 2011
- The neuropathological basis of clinical progression in multiple sclerosisActa Neuropathologica, 2011
- Experimental Autoimmune Encephalomyelitis in the MouseCurrent Protocols in Immunology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001